Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mod Healthc. 2012 Aug 20;42(34):6-7, 16, 1.

Doctors of interest. Recipients of suspect drug-company payments academic medical centers, have drawing attention of federal fraud enforcers.

Abstract

As the federal government begins to focus more on wasteful healthcare spending, doctors' relationships with drug companies are coming under scrutiny. Many times, those relationships are legitimate, says Mary Riordan, left, a senior counsel to HHS' inspector general's office. "There are other situations where the relationship between the doctor and the manufacturer is suspect".

PMID:
23156819
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk